1. Rykov S. (2003) Organizatsiya meditsinskoy pomoshi i medico-sotsialnoy reabilitatsii slepym i slabovidyashchim detyam: problem i puti ikh resheniya [Organization of medical care and medical and social rehabilitation for blind and visually impaired children: problems and solutions]. Ukrainskiy meditsinskiy zhurnal, vol. 3 (35), pp. 34–39.
2. Bezdetko P. (2017) Chto takoe myopiya? Vzglyad na harakter klinicheskogo techeniya i nekotorie aspect farmakologicheskogo lecheniya [What is myopia? A look at the nature of the clinical course and some aspect of pharmacological treatment]. Oftalmologiya. Vostochnaya Yevropa, vol. 7 (2), pp. 222–239.
3. Bezdetko P., Ilyina Y., Dobritsa Y. (2018) Effectivnost primeneniya diyeticheskoy dobavki «VisiloTON® complex» pri patologicheskoy miopii [The effectiveness of the dietary supplement “VisiloTON® complex” in pathological myopia]. Oftalmologiya. Vostochnaya Yevropa, vol. 8 (3), pp. 418–424.
4. Pan C.V., Ramamurthy D., Saw S.M. (2012) Worldwide prevalence and risk factors for myopia. Ophthalm. Physiol. Opt., vol. 32, pp. 3–16.
5. Czepita D. (2008) Prevalence of myopia and hyperopia among urban and rural schoolchildren. Ann. Acad. Med. Stetin., vol. 54, pp. 17–21.